Comparing Different Timings for Periodontal Re-evaluation After Non-surgical Periodontal Therapy (NSPT)
NCT ID: NCT05088746
Last Updated: 2025-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
52 participants
OBSERVATIONAL
2021-06-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Fifty-two, ≥18-year old, otherwise healthy, periodontitis patients will be recruited at Centro di Odontoiatria, Università di Parma.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Timing of Periodontal Re-evaluation After Non-surgical Periodontal Therapy
NCT04826926
Timing of Re-evaluation After Steps I-II of Periodontal Therapy
NCT05892315
Clinical Relevance of Different Time of Periodontal Re-evaluation
NCT06086821
Novel Protocol for Supportive Periodontal Therapy
NCT05799261
The Effect of Time on the Outcome of Periodontal Treatment.
NCT05643287
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Visit 1 - Baseline -
* Informed consent, medical/dental history and demographics
* Record concomitant medications and smoking history
* Periodontal assessment by a blind and calibrated examiner, consisting of full mouth PPD, REC, BOP, PI, mobility and furcation involvement. PPD, REC, PI and BOP will be recorded at 6 sites per tooth.
* Standardized peri-apical x-rays for the sites with PPD≥5mm, as per standard of practice (if not already available within the previous 6 months)
* Intra-oral 3D scan
* Oral hygiene instructions and demonstration of self-performed oral hygiene measures
* PROMs questionnaires
* Saliva collection and GCF collection from the deepest pockets (maximum of 5 sites)
Visit 2 and 3 - NSPT - (and extra visit 3.1 and 3.2 if needed) (within 60 days from baseline)
* Update medical/dental history and record adverse events and/or concomitant medications
* NSPT, consisting in the careful removal of hard and soft deposits with ultrasonic instruments at infected sites performed by an experienced clinician following the principles of minimally invasive non-surgical therapy (MINST). A quadrant approach will be adopted and it will be left to the discretion of the clinician to choose whether to instrument 1 or 2 quadrants at a time and the length of session visits. Hence, 2 to 4 sessions of NSPT with an interval of 1 week between each other will be performed. During NSPT, teeth considered hopeless will be extracted as per standard of practice.
* Reinforcement of oral hygiene instructions
* PROMs questionnaires
Extra visits outside the study protocol may be arranged in case the patients need extractions or other dental treatments besides NSPT.
Visit 4 (4-6 weeks from the end of NSPT)
* Update medical/dental history and record adverse events and/or concomitant medications
* Visual inspection of signs of inflammation and plaque
* Supragingival polish and reinforcement of oral hygiene instructions
* PROMs questionnaires
* Intra-oral 3D scan
Visit 5 (3-4 months from the end of NSPT)
* Update medical/dental history and record adverse events and/or concomitant medications
* Periodontal assessment by a blind and calibrated examiner, consisting of full mouth PPD, REC, BOP, PI, mobility and furcation involvement. PPD, REC, PI and BOP will be recorded at 6 sites per tooth.
* PROMs questionnaires
* Intra-oral 3D scan
* Saliva collection and GCF collection from the same sites identified at baseline
* Supragingival polish and reinforcement of oral hygiene instructions
Visit 6 (6-8 months from the end of NSPT)
* Update medical/dental history and record adverse events and/or concomitant medications
* Periodontal assessment by a blind and calibrated examiner, consisting of full mouth PPD, REC, BOP, PI, mobility and furcation involvement. PPD, REC, PI and BOP will be recorded at 6 sites per tooth.
* PROMs questionnaires
* Intra-oral 3D scan
* Saliva collection and GCF collection from the same sites identified at baseline
* Supragingival polish and reinforcement of oral hygiene instructions
Visit 7 (12 months ± 14 days from the end of NSPT)
* Update medical/dental history and record adverse events and/or concomitant medications
* Periodontal assessment by a blind and calibrated examiner, consisting of full mouth PPD, REC, BOP, PI, mobility and furcation involvement. PPD, REC, PI and BOP will be recorded at 6 sites per tooth.
* PROMs questionnaires
* Intra-oral 3D scan
* Standardized peri-apical x-rays
* Saliva collection and GCF collection from the same sites identified at baseline
* Supragingival polish and reinforcement of oral hygiene instructions
Photos and videos may be taken/recorded in any of the study visits for documentation purposes. The subject will not be identifiable from those photos/videos.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-surgical periodontal therapy
Non-surgical periodontal therapy
NSPT will be performed following the principles of minimally invasive non-surgical therapy (MINST) described by Nibali et al. (Nibali et al., 2015, Nibali et al., 2019)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-surgical periodontal therapy
NSPT will be performed following the principles of minimally invasive non-surgical therapy (MINST) described by Nibali et al. (Nibali et al., 2015, Nibali et al., 2019)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willingness to read and sign a copy of the Informed Consent Form after reading the Patient Information Sheet, and after the nature of the study has been fully explained
* Clinical evidence of periodontitis, defined as the presence of interdental clinical attachment loss detectable at ≥2 non-adjacent teeth or buccal or oral clinical attachment loss ≥3mm with pocketing \>3 mm detectable at ≥2 teeth (Tonetti et al., 2018)
* Not having received subgingival instrumentation within the previous 12 months
Exclusion Criteria
* Antibiotic, anti-inflammatory or anticoagulant therapy during the month preceding the baseline exam.
* In treatment with drugs that induce gingival overgrowth
* History of conditions requiring prophylactic antibiotic coverage prior to invasive dental procedures
* History of alcohol or drug abuse.
* Self-reported pregnancy or lactation (this criterion is due to oral tissue changes related to pregnancy and nursing, which can affect interpretation of study results).
* Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with trial participation or investigational product administration or may interfere with the interpretation of trial results and, in the judgement of the investigator, would make the subject inappropriate for entry into this trial.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Parma
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof Elena Calciolari
Principal Investigator. DDS, MS., PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centro Universitario di Odontoiatria
Parma, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.